Last reviewed · How we verify

NCT06068751

Aerobic Exercise and Neck Exercises in Pediatric Migraine Treatment

Status unknown NA Last updated 5 October 2023
What this trial tests

NA trial testing Aerobic Exercise in Migraine in Children in 60 participants. Status unknown.

Timeline
22 September 2023
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorGaziosmanpasa Research and Education Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date22 September 2023
Primary completion31 December 2023
Estimated completion31 December 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gaziosmanpasa Research and Education Hospital

Who can join

Adults 6 to 17, any sex, with Migraine in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled single-blind trial will include 60 pediatric migraine patients. Participants will be divided into two groups: one performing aerobic exercise, and the other conducting neck exercises. Assessments include attack frequency, severity, duration, and neck pain over three months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Aerobic Exercise

Trials testing the same drug.

Other recruiting trials for Migraine in Children

Currently open trials in the same condition.

Other Gaziosmanpasa Research and Education Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06068751.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing